Weekly shot tested to control blood sugar and shed pounds
NCT ID NCT06611930
Summary
This study tested whether a new weekly injection called CK-0045 could help people with type 2 diabetes and overweight or obesity better control their blood sugar after meals and lose weight. About 90 participants received either one of two doses of CK-0045 or a placebo shot for 16 weeks. The trial was terminated early, and its main goal was to see if the treatment improved post-meal glucose levels and body weight compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Reserach Services Mannheim GmbH
Mannheim, Baden-Wurttemberg, 68167, Germany
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, D-41460, Germany
Conditions
Explore the condition pages connected to this study.